Oregon Drops Proposed Psilocybin Fee Increases and Plans New Rulemaking
By Green Rush Advisory Group
Oregon Health Authority has announced it will not proceed with the current psilocybin rulemaking process, which included proposed increases in license fees. The agency will instead begin a new process focused on changes unrelated to those proposed fee increases.
For existing licensees and entrepreneurs evaluating Oregon’s regulated psilocybin sector, this removes a proposed cost increase from the immediate planning picture. Further rule changes remain on the horizon.
What OHA announced
In an update to its distribution list, OHA’s Medical Cannabis & Psilocybin section, known as MCAP, said the agency will not adopt final rules from the current proceeding. OHA attributed the decision to feedback received through the Oregon Psilocybin Advisory Board, rule advisory committees, and the public comment period. The agency’s Administrative Rules and Rulemaking Process webpage also confirms that the proposed fee increases will not be adopted.
The scope of that announcement matters: OHA is ending the current rulemaking process. Other proposed changes will need to move through the new process before they can become final.
What comes next
According to MCAP’s email, the agency expects to begin a new rulemaking process in the coming weeks, with public comment anticipated in December and a planned effective date of January 15, 2027. These are projected milestones; the forthcoming notice and final adopted rules will establish the actual schedule and requirements.
OHA says the new process will address proposals unrelated to the fee changes. The announcement does not identify the complete replacement package, so operators should review the new language when it is released before drawing conclusions about operational impacts.
MCAP also said OHA will publish documents responding to questions and requests concerning the psilocybin program’s budget. Those materials may help stakeholders evaluate the agency’s funding needs and participate more effectively in future discussions.
What this means for business planning
From a business planning perspective, there is a meaningful difference between a proposed expense and an adopted obligation. Anyone who incorporated the proposed increases into a forecast should revisit that assumption and clearly distinguish current fees from possible future changes.
The announcement does not promise a permanent freeze on fees. It also does not, by itself, establish improved demand, stronger margins, or a higher business value. Those questions still require an examination of the individual operation and its market.
For prospective entrants, the practical approach is to keep evaluating the full cost of opening and operating while monitoring the replacement rules. For existing operators, this is an opportunity to prepare specific comments explaining how proposed requirements would affect staffing, administrative work, client access, and operating costs.
Public participation affected the outcome
OHA expressly connected its decision to stakeholder feedback. That gives licensees and prospective applicants a concrete reason to stay involved in the next proceeding.
When the new proposal is published, read the actual rule language, identify the provisions that affect your operation, and support comments with practical examples and cost estimates where possible. Watch for the official comment deadline and submission instructions on OHA’s rulemaking page.
Questions about evaluating an Oregon psilocybin business opportunity or planning market entry? Contact Green Rush Advisory Group at acquisitions@green-rush.us.
Source note: This update draws on MCAP’s distribution-list announcement and OHA’s public rulemaking webpage. The anticipated December comment period and forthcoming budget documents were described in the email announcement.